EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile

Adam M Ressler, Krishna Rao, Vincent B Young

Gastroenterology Clinics of North America · 2025

DOI: 10.1016/j.gtc.2025.02.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gastroenterology Clinics of North America, 2025. Verfasst von Adam M Ressler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Infectious Disease Division, University of Michigan Medicine, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Clostridium Infections, Anti-Bacterial Agents, Clostridioides difficile, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) and recurrent CDI (rCDI) are significant causes of morbidity and mortality. The microbiome plays a significant role in the body's defense against CDI and rCDI. Antibiotics can cause significant injury to the microbiome which leads to an increased risk of CDI and rCDI. Ongoing perturbations of the microbiome perpetuate this risk. Antibiotic treatments for CDI can kill C difficile but also can impact the microbiome. Microbiome therapeutics are effective in restoring the function of the gut microbiota and re-establishing colonization resistance. The field of microbiome therapeutics is evolving with newer, more refined, modalities in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium InfectionsAnti-Bacterial AgentsClostridioides difficileGastrointestinal MicrobiomeHumansFecal Microbiota TransplantationRecurrenceSecondary PreventionProbiotics

Stichwörter der Autor:innen

C difficileMicrobiomeMicrobiome therapeuticsRecurrence

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Infectious Disease Division, University of Michigan Medicine, Ann Arbor, MI, USA.
  • Department of Internal Medicine, Infectious Disease Division, University of Michigan Medicine, Ann Arbor, MI, USA; Department of Microbiology & Immunology. Electronic address: youngvi@umich.edu.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Ressler, A. M., Rao, K., & Young, V. B. (2025). Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile. Gastroenterology Clinics of North America. https://doi.org/10.1016/j.gtc.2025.02.005

Vancouver

Ressler AM, Rao K, Young VB. Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile. Gastroenterology Clinics of North America. 2025. doi:10.1016/j.gtc.2025.02.005

BibTeX
@article{Ressler2025,
  author = {Ressler, Adam M and Rao, Krishna and Young, Vincent B},
  title = {Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile},
  journal = {Gastroenterology Clinics of North America},
  year = {2025},
  doi = {10.1016/j.gtc.2025.02.005}
}
Kostenlos starten →